Quantinuum (NASDAQ:QNT) Issues Earnings Results, Misses Estimates By $0.02 EPS

Quantinuum (NASDAQ:QNT) posted its earnings results on Tuesday. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02), FiscalAI reports. The firm had revenue of $8.00 million for the quarter.

Here are the key takeaways from Quantinuum’s conference call:

• Revenue rose 279% year over year to $8 million, while management raised its 2026 revenue outlook to $28 million–$32 million and expects more than 100% revenue growth in 2027 based on current bookings and backlog.
• Commercial momentum accelerated, with year-to-date bookings of approximately $81 million and a projected full-year bookings target of at least $120 million. Oracle agreed to purchase a Helios system for deployment in a U.S. Oracle Cloud Infrastructure data center under a multi-year partnership.
• Quantinuum reported progress on its technology roadmap, including validation of Sol product-candidate traps, continued development of Apollo, and demonstrations of near five-nines logical fidelity using new quantum error-correction codes on Helios.
• Developer and ecosystem engagement expanded to more than 180 organizations using Quantinuum Nexus, alongside partnerships with Oracle, HPE, NVIDIA and others to integrate quantum computing with AI and high-performance computing workflows.
• The company remains deeply loss-making and investment-heavy, reporting a $596.5 million GAAP net loss and a $73 million non-GAAP net loss in Q2. Although much of the GAAP impact came from one-time IPO-related stock compensation, management expects continued incremental investment in technology, manufacturing, supply chain and public-company infrastructure.

Quantinuum Stock Up 3.7%

Shares of QNT opened at $58.16 on Wednesday. Quantinuum has a fifty-two week low of $47.06 and a fifty-two week high of $86.79. The business has a 50-day moving average price of $62.71.

Analysts Set New Price Targets

A number of research firms recently commented on QNT. Craig Hallum initiated coverage on Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating and a $100.00 price target for the company. Evercore began coverage on shares of Quantinuum in a report on Monday, June 29th. They issued an “outperform” rating and a $98.00 target price for the company. Bank of America initiated coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating and a $100.00 price objective for the company. Wall Street Zen cut Quantinuum from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. Finally, Zacks Research raised Quantinuum to a “hold” rating in a research report on Tuesday, June 30th. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $98.33.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Analysts reaffirm bullish ratings and raise visibility. Rosenblatt Securities reaffirmed its “buy” rating with a $155 price target, while Needham reiterated “buy” with a $100 target and Cantor Fitzgerald maintained an “overweight” rating with a $90 target. These targets imply substantial potential upside from current levels. Benzinga analyst rating reports
• Positive Sentiment: Oracle partnership strengthens commercialization prospects. Quantinuum will deploy its 98-qubit Helios system as a service within Oracle Cloud Infrastructure, allowing enterprise, artificial-intelligence, academic and research customers to access quantum computing without purchasing specialized hardware. The partnership could expand adoption and create a more practical path to recurring revenue. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: Revenue growth and guidance exceeded expectations. Second-quarter revenue reached $8 million, up 279% year over year. Quantinuum raised its fiscal 2026 revenue outlook to $28 million-$32 million, above the $26.6 million analyst consensus. Management also highlighted near-five-nines logical fidelity for Helios and supply-chain improvements. Quantinuum Reports Second Quarter 2026 Results
• Neutral Sentiment: Short-interest data provides little trading signal. Reported short interest was zero shares, with a zero-day short-interest ratio. The figure appears inconsistent and may reflect limited or incomplete post-IPO reporting, so it is not a reliable indication of investor positioning. Quantinuum short interest report
• Negative Sentiment: Quarterly loss modestly exceeded expectations. Quantinuum reported an adjusted loss of $0.28 per share versus the $0.26 consensus estimate. The company remains unprofitable, with analysts forecasting a full-year loss of approximately $1.61 per share, creating valuation and execution risks despite its growth prospects. Quantinuum quarterly earnings report

Insider Activity

In other Quantinuum news, Director Joseph Jimenez bought 66,665 shares of Quantinuum stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $60.00 per share, for a total transaction of $3,999,900.00. Following the completion of the purchase, the director directly owned 72,498 shares of the company’s stock, valued at approximately $4,349,880. This trade represents a 1,142.89% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Hal Barron purchased 250,000 shares of the stock in a transaction dated Friday, June 5th. The stock was acquired at an average cost of $60.00 per share, for a total transaction of $15,000,000.00. Following the transaction, the director owned 255,833 shares of the company’s stock, valued at approximately $15,349,980. This trade represents a 4,285.96% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders have purchased 411,032 shares of company stock valued at $24,661,920.

Hedge Funds Weigh In On Quantinuum

A hedge fund recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC acquired a new stake in shares of Quantinuum Inc. (NASDAQ:QNT) during the second quarter, according to its most recent filing with the SEC. The fund acquired 5,005 shares of the company’s stock, valued at approximately $409,000.

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.